Skip to Main Content

KMAP BULLETIN: REVISED: Autism Diagnosis and Diagnosticians Clinical Requirement

Date: 10/30/26

KMAP GENERAL BULLETIN 26140 (PDF)

REVISED: Effective for dates of service on or after November 1, 2026, individuals aged 20 years and younger with autism spectrum disorder (ASD) must receive a diagnosis from a Kansas Behavioral Sciences Regulatory Board (BSRB) clinical psychologist or qualified physician. A multidisciplinary diagnostic approach is preferred.

Qualified ASD Diagnostic Providers:

  • 11/112 (Psychologist)
  • 31/316 (Family Practitioner)
  • 31/318 (General Practitioner)
  • 31/326 (Neurologist)
  • 31/339 (Psychiatrist)
  • 31/345 (General Pediatrician [Developmental])
  • 31/349 (Exempt License Physician)
  • 31/351 (Indian Health Services) 

Qualified Kansas BSRB clinical psychologists must meet the following criteria:

  • A doctor’s degree in psychology or equivalent training; and
  • Two (2) years of supervised experience delivering BSRB-approved psychological services.

Qualified physicians include:

  • developmental/behavioral pediatricians
  • psychiatrists
  • neurologists
  • primary care physicians with documentation of additional training in the diagnosis of ASD

 

ASD Diagnostic Evaluation Requirements

  1. Diagnostic criteria and symptom severity level according to the most current edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM)
  2. Validated ASD diagnostic assessment tool such as the Autism Diagnostic Observation Schedule (ADOS) or the Childhood Autism Rating Scale (CARS)

ASD Diagnostic Evaluation Recommendations

  1. Cognitive evaluation through a validated tool such as the Clinical Adaptive test/Clinical Linguistic and Auditory Milestone Scale (CAT/CLAMS), Mullen Scales of Early Learning (MSEL), or Bayley Scales on Infant Development (BSID). Cognitive evaluation that was completed by the school district using a validated tool, may also be included.
  2. An adaptive behavior measure such as the Adaptive Behavior Assessment System (ABAS) or Vineland Adaptive Behavior Scale (VABS) may also be useful in the diagnostic process.

Autism Screening and Treatment

Once an individual is diagnosed with autism spectrum disorder by a qualified diagnostician as per this policy, they are eligible for autism treatment, including applied behavioral analysis (ABA) therapy, without the need for a re-evaluation of their autism spectrum disorder diagnosis. There is also no time limit on how soon they begin autism treatment, including ABA therapy, following their diagnosis of autism spectrum disorder.

Transition Provisions for Current Members

For individuals already approved and receiving autism treatment, including applied behavioral analysis (ABA) therapy, who have been diagnosed with autism spectrum disorder by a diagnostician who does not meet the updated diagnostician and/or diagnostic requirements as per this policy, they will have two (2) years to obtain an updated autism spectrum disorder diagnosis by a qualified diagnostician. The updated diagnosis does not necessarily need to involve a complete diagnostic evaluation as long as the diagnostic criteria in this policy are met and a qualified diagnostician is confirming the diagnosis.  The updated diagnosis must be based on diagnostic criteria established in this policy and confirmed by a qualified diagnostician. A validated ASD diagnostic tool, used either during the original diagnostic process or during the diagnostic re-evaluation by a qualified diagnostician, remains an essential element of the ASD diagnosis. 

Access to formal ASD diagnosis may involve an extended period of time, given the clinical complexity of the necessary evaluation. 1 When a beneficiary, whose screening evaluation suggests a possible ASD diagnosis, experiences a minimum wait time of twelve (12) months during which a formal diagnosis has not been achieved by a qualified diagnostician (MD, DO, PhD) because of access issues, a provisional diagnosis may be rendered by a master’s level practitioner. This “provisional diagnosis” exception and the management of it over time is explained below. 

A provisional ASD diagnosis will be respected for up to 24 months or until a formal diagnosis is rendered by a qualified provider (MD, DO, PhD), whichever occurs first. During this time, ABA therapy and other medically necessary services will be covered for the affected beneficiary.   

This timeline and the diagnostic process are to be tracked by the MCO as a matter of care coordination. 

This Exception Clause will be re-evaluated by KanCare every six months. This Exception Clause stands until it is rescinded by KanCare.   

A Note about the Diagnostic Evaluation Process

According to Bright Futures, Primary Care Providers (PCPs) should conduct ASD screening (such as the Modified Checklist for Autism in Toddlers [MCHAT]) at the 18-month and 24-month well child checks. Screening at other times may be appropriate if/when concern for ASD arises. It is a positive screening result that should trigger a formal evaluation process.   

Master’s degree providers qualified to complete assessment components of an ASD diagnostic evaluation may continue—indeed are encouraged—to do so. Providers completing assessments in preparation for review by a qualified diagnostician may also render differential diagnoses for review by a qualified diagnostician. Assessments, differential diagnoses, and elements of evaluations done by qualified providers, once completed, are to be reviewed and considered by qualified diagnosticians (MDs, DOs, PhDs) in rendering a final diagnosis. 

1Chen, Y.-H., Drye, M., Chen, Q., Fecher, M., Liu, G., & Guthrie, W. (2023). Delay from screening to diagnosis in autism spectrum disorder: Results from a large national health research network. The Journal of Pediatrics, 260, 113514. https://doi.org/10.1016/j.jpeds.2023.113514 2 Hyman SL, Levy SE, Myers SM; COUNCIL ON CHILDREN WITH DISABILITIES, SECTION ON DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS. Identification, Evaluation, and Management of Children With Autism Spectrum Disorder. Pediatrics. 2020 Jan;145(1):e20193447. 

Note: The effective date of the policy is November 1, 2026. The implementation of State policy by the KanCare Managed Care Organizations (MCOs) may vary from the date noted in the Kansas Medical Assistance Program (KMAP) bulletins. The KanCare Open Claims Resolution Log on the KMAP Bulletins page documents the MCO system status for policy implementation and any associated reprocessing completion dates once the policy is implemented.


For changes resulting from this bulletin, view the updated Mental Health Fee-for-Service Provider Manual, pages 8-47 and 8-48 and Professional Fee-for-Service Provider Manual, pages 8-11 and 8-12.